The invention relates to azetidinyl, pyrrolidinyl, piperidinyl, and hexahydroazepinyl compounds of Formula I and pharmaceutically acceptable salts, prodrugs, or solvates thereof, wherein R
1
-R
3
and Z are defined as set forth in the specification. The invention is also directed to the use compounds of Formula I to treat, prevent or ameliorate a disorder responsive to the blockade of calcium channels, and particularly N-type calcium channels. Compounds of the present invention are especially useful for treating pain.
本发明涉及式I的氮
杂环化合物,包括氮杂丙环基、
吡咯烷基、
哌啶基和六氢杂环庚基,以及其药学上可接受的盐、前药或溶剂化物,其中R1-R3和Z如规范中所述。本发明还涉及使用式I的化合物治疗、预防或改善对
钙通道封锁有反应的疾病,特别是N型
钙通道。本发明的化合物特别适用于治疗疼痛。